Carson Wealth (CWM LLC)’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
123,686
-32,858
-21% -$282K ﹤0.01% 1534
2025
Q4
$1.63M Buy
156,544
+38,181
+32% +$401K ﹤0.01% 1243
2025
Q3
$1.05M Buy
118,363
+76,957
+186% +$549K ﹤0.01% 1378
2025
Q2
$239K Buy
41,406
+13,053
+46% +$80K ﹤0.01% 2021
2025
Q1
$187K Buy
28,353
+25,497
+893% +$199K ﹤0.01% 1965
2024
Q4
$25K Buy
2,856
+1,620
+131% +$23.3K ﹤0.01% 3289
2024
Q3
$24K Buy
1,236
+702
+131% +$14.2K ﹤0.01% 3243
2024
Q2
$11K Buy
534
+530
+13,250% +$10.9K ﹤0.01% 3491
2024
Q1
$0 Buy
+4
New +$78 ﹤0.01% 4534
2023
Q4
Sell
-413
Closed -$4K 4342
2023
Q3
$4K Sell
413
-161
-28% -$1.64K ﹤0.01% 3572
2023
Q2
$6K Buy
+574
New +$6.79K ﹤0.01% 3358
2023
Q1
Sell
-20
Closed 4207
2022
Q4
$0 Sell
20
-12
-38% -$174 ﹤0.01% 4114
2022
Q3
$0 Buy
+32
New +$494 ﹤0.01% 4060
2022
Q2
Sell
-10
Closed 3956
2022
Q1
$0 Buy
+10
New +$144 ﹤0.01% 3704

Other funds holding KURA

Carson Wealth (CWM LLC)'s KURA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Kura Oncology (KURA) stake by 21% in Q1 2026, selling an estimated $282K and leaving 123,686 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Carson Wealth (CWM LLC) first reported a position in KURA in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.63M in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 123,686 shares of Kura Oncology worth $1.01M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 32,858 Kura Oncology shares in Q1 2026, an estimated $282K.
  • Kura Oncology made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1534 holding.
  • Carson Wealth (CWM LLC) first reported a position in Kura Oncology in Q1 2022 and has held it in 14 quarters since.
  • Carson Wealth (CWM LLC)'s Kura Oncology position peaked at $1.63M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.